BASEL, Switzerland,
April 25, 2012 /PRNewswire/ --
- Exclusive expansion into new markets for JumpStart
- Integrated offer with Seed Care
- Sustainable solution for growers
Syngenta and Novozymes today announced a global agreement under
which Syngenta will work with Novozymes to commercialize the
Novozymes technology JumpStart, a seed-applied
biological which increases phosphate solubility in the soil.
The two companies will jointly develop the market for JumpStart in
combination with Syngenta's Seed Care portfolio on crops including
cereals and corn. The agreement extends the geographic
potential of JumpStart, currently sold mainly in North America, to the rest of the world.
Phosphorus is an essential macronutrient for the healthy growth
of young plants. JumpStart is based on a unique fungus
Penicillium bilaii, which increases phosphate uptake into
the plant through the root system. The market potential for
seed-applied technologies to increase phosphate efficiency is
estimated at over $100 million.
John Atkin, COO Syngenta, said:
"We are pleased to enter into this agreement with Novozymes which
marks a further addition to our growing range of bioactives.
Our Seed Care portfolio already offers best-in-class control of
insects and disease together with crop enhancement benefits.
With the addition of JumpStart, growers will now gain the added
advantage of improved phosphate efficiency."
Thomas Videbaek, Executive Vice
President Novozymes, commented: "Partnering with Syngenta supports
our strategic goal to provide the world with natural and biological
solutions to help farmers worldwide increase yields to feed the
world's growing population."
Syngenta is one of the world's leading companies with more than
26,000 employees in over 90 countries dedicated to our purpose:
Bringing plant potential to life. Through world-class science,
global reach and commitment to our customers we help to increase
crop productivity, protect the environment and improve health and
quality of life. For more information about us please go to
www.syngenta.com
|
Cautionary Statement Regarding Forward-Looking
Statements
This
document contains forward-looking statements, which can be
identified by terminology such as 'expect', 'would', 'will',
'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on
track' and similar expressions. Such statements may be subject to
risks and uncertainties that could cause the actual results to
differ materially from these statements. We refer you to Syngenta's
publicly available filings with the U.S. Securities and Exchange
Commission for information about these and other risks and
uncertainties. Syngenta assumes no obligation to update
forward-looking statements to reflect actual results, changed
assumptions or other factors. This document does not constitute, or
form part of, any offer or invitation to sell or issue, or any
solicitation of any offer, to purchase or subscribe for any
ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form
the basis of, or be relied on in connection with, any contract
therefor.
|
|
Syngenta International AG
|
Media
contact:
|
Analyst/Investor contacts:
|
|
Media
Office
|
Medard
Schoenmaeckers
|
Jennifer
Gough
|
|
CH-4002
Basel
|
Switzerland +41 61 323 2323
|
Switzerland +41 61 323 5059
|
|
Switzerland
|
|
USA
+1 202 737 6521
|
|
Tel: +41
61 323 23 23
|
|
|
|
Fax: +41
61 323 24 24
|
|
|
|
www.syngenta.com
|
|
|
SOURCE Syngenta